Antimicrobial Resistance News and Research

RSS

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

15 Jul 2022

Acknowledging AMR in regulatory frameworks for drug approvals could improve the availability of new antibiotics

The appropriate use of existing antibiotics and the development of new antibiotics targeting drug-resistant infections can slow the emergence, spread, and consequences of antimicrobial resistance (AMR); however, antibiotic research and development (R&D) has not responded to the urgent need for new antibiotics.

15 Jul 2022

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

The COVID-19 pandemic pushed back years of progress made in combating antimicrobial resistance (AR) in the United States.

14 Jul 2022

Researchers unravel mechanism that underlies failure of staph vaccine trials

For the most part, the bacterium Staphylococcus aureus is common and harmless, posing no threat to humans with whom they coexist.

7 Jul 2022

New study discloses the reason behind the disappearance of highly infectious cholera variant

A new study reveals why a highly infectious variant of the cholera bug, which caused large disease outbreaks in the early 1990s, did not cause the eighth cholera pandemic as feared – but instead unexpectedly disappeared.

5 Jul 2022

LSHTM and Reckitt launch new Forum to advance understanding of hygiene

The Reckitt Hygiene Forum, which aims to advance understanding of hygiene as the foundation of public health, has been launched as part of a five-year partnership between the London School of Hygiene & Tropical Medicine (LSHTM) and Reckitt.

29 Jun 2022

Drug-resistant typhoid needs to be treated as a global problem

The bacteria that causes typhoid fever is becoming increasingly resistant to common antibiotics used to treat the disease, with resistant strains spreading to hundreds of countries in the past three decades, new analysis shows.

29 Jun 2022

Shapeshifting behavior of E. coli may offer clues to combat urinary tract infections

Urinary tract infections are both very common and potentially very dangerous. More than half of all Australian women will suffer from a UTI in their lifetime, and nearly one in three women will have an infection requiring treatment with antibiotics before the age of 24.

28 Jun 2022

Study links post-COVID symptoms with alterations in gut microbiota

A team of scientists has recently highlighted the significance of gut microbiota alterations induced by SARS-CoV-2 in triggering post-COVID-19 symptoms.

23 Jun 2022

Research may open door to the design of a better structured rabies vaccine

Rabies virus kills a shocking 59,000 people each year, many of them children. Some victims, especially kids, don't realize they've been exposed until it is too late.

17 Jun 2022

Extensively drug-resistant Neisseria gonorrhoeae strain recently identified in Austria

Given that there is no vaccine available against gonorrhea, diagnosing this sexually transmitted infection early, treating it effectively and notifying sexual partners are cornerstones of controlling disease spread.

16 Jun 2022

Research reveals a potential Achilles heel in the protective layers surrounding Gram-negative bacteria

A new study published in Nature today has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

15 Jun 2022

Study reveals how common drug-resistant superbug responds to ‘last resort’ antibiotic

A study published today in Cell Reports reveals how populations of a bacterium called Pseudomonas respond to being treated with Colistin, a 'last resort' antibiotic for patients who have developed multi-drug resistant infections.

7 Jun 2022

UK and Sweden commit to enhance co-operation in the life sciences

Today (27 May 2022), Parliamentary Under-Secretary of State for Innovation at the Department of Health and Social Care, Lord Kamall, and the Swedish Minister for Education, Anna Ekström, signed a Memorandum of Understanding (MoU) committing the UK and Sweden to ongoing co-operation in the life sciences.

27 May 2022

Researchers discover bifunctional lipopeptide antibiotic with a low resistance potential

Through bioinformatic prospecting, researchers discovered and synthesized a novel, naturally inspired bifunctional lipopeptide antibiotic with a low resistance potential.

27 May 2022

Exposure of microbial communities to antibiotics could facilitate the spread of plasmid-encoded genes

DNA molecules called plasmids – some of which protect bacteria from antibiotics – can spread rapidly through bacterial "communities" that are treated with antibiotics, new research shows.

27 May 2022

Researchers focus on how bacterial cells adapt and resist antibiotics

Treatment of severe infections caused by pathogenic bacteria relies on ‘last resort’ antibiotics, but rising resistance by ‘superbugs’ to most clinically approved drugs leaves patients exposed to possible fatalities.

26 May 2022

STIs could be prevented with a dose of doxycycline after unprotected sex

A significant proportion of bacterial sexually transmitted infections (STIs) - gonorrhea, chlamydia or syphilis - were prevented with a dose of doxycycline after unprotected sex, according to preliminary results of a clinical trial that closed early because it was very effective for men who have sex with men and transgender women who are living with HIV or are taking HIV pre-exposure prophylaxis (PrEP).

25 May 2022

HKUMed researchers report the effects of SARS-CoV-2 on bone metabolism

A research team led by Professor Kelvin Yeung Wai-kwok and Dr Jasper Chan Fuk-woo from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that SARS-CoV-2 infection can cause inflammatory activation of bone resorption cells, leading to severe bone loss during the acute and post-recovery phases of COVID-19.

25 May 2022

University of Minnesota receives $66 million to establish new antiviral drug discovery center

The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.

23 May 2022

Antimicrobial Resistance News and Research

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Acknowledging AMR in regulatory frameworks for drug approvals could improve the availability of new antibiotics

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

Researchers unravel mechanism that underlies failure of staph vaccine trials

New study discloses the reason behind the disappearance of highly infectious cholera variant

LSHTM and Reckitt launch new Forum to advance understanding of hygiene

Drug-resistant typhoid needs to be treated as a global problem

Shapeshifting behavior of E. coli may offer clues to combat urinary tract infections

Study links post-COVID symptoms with alterations in gut microbiota

Research may open door to the design of a better structured rabies vaccine

Extensively drug-resistant Neisseria gonorrhoeae strain recently identified in Austria

Research reveals a potential Achilles heel in the protective layers surrounding Gram-negative bacteria

Study reveals how common drug-resistant superbug responds to ‘last resort’ antibiotic

UK and Sweden commit to enhance co-operation in the life sciences

Researchers discover bifunctional lipopeptide antibiotic with a low resistance potential

Exposure of microbial communities to antibiotics could facilitate the spread of plasmid-encoded genes

Researchers focus on how bacterial cells adapt and resist antibiotics

STIs could be prevented with a dose of doxycycline after unprotected sex

HKUMed researchers report the effects of SARS-CoV-2 on bone metabolism

University of Minnesota receives $66 million to establish new antiviral drug discovery center

Microbiology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News